[1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum

C162H121F3N16O3Pt4S-8 — CID 163850882

IUPAC[1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum
SMILESCc1ccnc(Oc2[c-]c(N(c3[c-]c(-n4ccn(C)c4=[Pt])ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1.Cn1ccn(-c2[c-]c(N(c3[c-]c(Oc4cc(C(C)(C)C)ccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].Cn1ccn(-c2[c-]c(N(c3[c-]c(Oc4cc(C(F)(F)F)ccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].Cn1ccn(-c2[c-]c(N(c3[c-]c(Sc4ccccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt]
InChIInChI=1S/C43H36N4O.C40H27F3N4O.C40H30N4O.C39H28N4S.4Pt/c1-43(2,3)34-24-25-44-41(28-34)48-38-21-12-20-37(30-38)47(36-19-11-18-35(29-36)46-27-26-45(4)31-46)42-39(32-14-7-5-8-15-32)22-13-23-40(42)33-16-9-6-10-17-33;1-45-23-24-46(28-45)32-15-8-16-33(26-32)47(34-17-9-18-35(27-34)48-38-25-31(21-22-44-38)40(41,42)43)39-36(29-11-4-2-5-12-29)19-10-20-37(39)30-13-6-3-7-14-30;1-30-22-23-41-39(26-30)45-36-19-10-18-35(28-36)44(34-17-9-16-33(27-34)43-25-24-42(2)29-43)40-37(31-12-5-3-6-13-31)20-11-21-38(40)32-14-7-4-8-15-32;1-41-25-26-42(29-41)32-17-10-18-33(27-32)43(34-19-11-20-35(28-34)44-38-23-8-9-24-40-38)39-36(30-13-4-2-5-14-30)21-12-22-37(39)31-15-6-3-7-16-31;;;;/h5-28H,1-4H3;2-25H,1H3;3-26H,1-2H3;2-26H,1H3;;;;/q4*-2;;;;
InChIKeyGQRPMNJYVOQXMV-UHFFFAOYSA-N
MW3209.23 g/mol
LogP40.93
Rot. Bonds32

About [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum

[1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum (PubChem CID 163850882) has the molecular formula C162H121F3N16O3Pt4S-8 and a molecular weight of 3209.23 g/mol. Its IUPAC name is [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum
PubChem CID163850882
Molecular FormulaC162H121F3N16O3Pt4S-8
Molecular Weight3209.23 g/mol
Exact Mass3206.81
IUPAC Name[1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum
SMILESCc1ccnc(Oc2[c-]c(N(c3[c-]c(-n4ccn(C)c4=[Pt])ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1.Cn1ccn(-c2[c-]c(N(c3[c-]c(Oc4cc(C(C)(C)C)ccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].Cn1ccn(-c2[c-]c(N(c3[c-]c(Oc4cc(C(F)(F)F)ccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].Cn1ccn(-c2[c-]c(N(c3[c-]c(Sc4ccccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt]
InChIInChI=1S/C43H36N4O.C40H27F3N4O.C40H30N4O.C39H28N4S.4Pt/c1-43(2,3)34-24-25-44-41(28-34)48-38-21-12-20-37(30-38)47(36-19-11-18-35(29-36)46-27-26-45(4)31-46)42-39(32-14-7-5-8-15-32)22-13-23-40(42)33-16-9-6-10-17-33;1-45-23-24-46(28-45)32-15-8-16-33(26-32)47(34-17-9-18-35(27-34)48-38-25-31(21-22-44-38)40(41,42)43)39-36(29-11-4-2-5-12-29)19-10-20-37(39)30-13-6-3-7-14-30;1-30-22-23-41-39(26-30)45-36-19-10-18-35(28-36)44(34-17-9-16-33(27-34)43-25-24-42(2)29-43)40-37(31-12-5-3-6-13-31)20-11-21-38(40)32-14-7-4-8-15-32;1-41-25-26-42(29-41)32-17-10-18-33(27-32)43(34-19-11-20-35(28-34)44-38-23-8-9-24-40-38)39-36(30-13-4-2-5-14-30)21-12-22-37(39)31-15-6-3-7-16-31;;;;/h5-28H,1-4H3;2-25H,1H3;3-26H,1-2H3;2-26H,1H3;;;;/q4*-2;;;;
InChIKeyGQRPMNJYVOQXMV-UHFFFAOYSA-N
XLogP40.93
TPSA131.65 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds32
Heavy Atoms189
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003209.23
LogP ≤ 540.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum (CID 163850882) is [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum is Cc1ccnc(Oc2[c-]c(N(c3[c-]c(-n4ccn(C)c4=[Pt])ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1.Cn1ccn(-c2[c-]c(N(c3[c-]c(Oc4cc(C(C)(C)C)ccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].Cn1ccn(-c2[c-]c(N(c3[c-]c(Oc4cc(C(F)(F)F)ccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].Cn1ccn(-c2[c-]c(N(c3[c-]c(Sc4ccccn4)ccc3)c3c(-c4ccccc4)cccc3-c3ccccc3)ccc2)c1=[Pt].
What is the InChIKey of [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum?
The InChIKey is GQRPMNJYVOQXMV-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H36N4O.C40H27F3N4O.C40H30N4O.C39H28N4S.4Pt/c1-43(2,3)34-24-25-44-41(28-34)48-38-21-12-20-37(30-38)47(36-19-11-18-35(29-36)46-27-26-45(4)31-46)42-39(32-14-7-5-8-15-32)22-13-23-40(42)33-16-9-6-10-17-33;1-45-23-24-46(28-45)32-15-8-16-33(26-32)47(34-17-9-18-35(27-34)48-38-25-31(21-22-44-38)40(41,42)43)39-36(29-11-4-2-5-12-29)19-10-20-37(39)30-13-6-3-7-14-30;1-30-22-23-41-39(26-30)45-36-19-10-18-35(28-36)44(34-17-9-16-33(27-34)43-25-24-42(2)29-43)40-37(31-12-5-3-6-13-31)20-11-21-38(40)32-14-7-4-8-15-32;1-41-25-26-42(29-41)32-17-10-18-33(27-32)43(34-19-11-20-35(28-34)44-38-23-8-9-24-40-38)39-36(30-13-4-2-5-14-30)21-12-22-37(39)31-15-6-3-7-16-31;;;;/h5-28H,1-4H3;2-25H,1H3;3-26H,1-2H3;2-26H,1H3;;;;/q4*-2;;;;.
What are the key properties of [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum?
[1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum has a molecular weight of 3209.23 g/mol, XLogP of 40.93, 32 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-(N-[3-[(4-tert-butyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-(3-pyridin-2-ylsulfanylbenzene-2-id-1-yl)anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-[3-(2,6-diphenyl-N-[3-[[4-(trifluoromethyl)-2-pyridinyl]oxy]benzene-2-id-1-yl]anilino)benzene-2-id-1-yl]-3-methylimidazol-2-ylidene]platinum;[1-methyl-3-[3-(N-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-2,6-diphenylanilino)benzene-2-id-1-yl]imidazol-2-ylidene]platinum is sourced from PubChem (CID 163850882), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).